Overview
Myopericytoma is a rare benign soft tissue tumor that arises from perivascular myoid cells (pericytes), which are cells that normally surround small blood vessels. This tumor belongs to the family of perivascular tumors, which also includes myofibroma and glomus tumors. Myopericytomas most commonly present as a slow-growing, painless, well-circumscribed nodule in the subcutaneous tissue or dermis of the extremities, particularly the lower limbs. They can also occur in other locations including the head, neck, and trunk. The tumors are typically solitary, although rare cases of multifocal myopericytomas have been reported. Histologically, myopericytomas are characterized by a concentric perivascular proliferation of oval to spindle-shaped myoid cells arranged around thin-walled blood vessels. The tumor cells express smooth muscle actin, reflecting their pericytic origin. While the vast majority of myopericytomas are benign, exceedingly rare malignant variants have been described in the literature, which may exhibit infiltrative growth, nuclear atypia, increased mitotic activity, and potential for metastasis. The primary treatment for myopericytoma is complete surgical excision, which is generally curative for benign lesions. Local recurrence is uncommon after adequate resection. No specific systemic therapy is typically required for benign myopericytomas. For the rare malignant cases, wider excision and close follow-up are recommended, though standardized treatment protocols are lacking due to the extreme rarity of malignant transformation. Prognosis for typical benign myopericytoma is excellent.
Sporadic
Usually appears on its own, not inherited from a parent
Adult
Begins in adulthood (age 18 or older)
Treatments
No FDA-approved treatments are currently listed for Myopericytoma.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Myopericytoma at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Myopericytoma.
Community
No community posts yet. Be the first to share your experience with Myopericytoma.
Start the conversation →Latest news about Myopericytoma
No recent news articles for Myopericytoma.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Myopericytoma
What is Myopericytoma?
Myopericytoma is a rare benign soft tissue tumor that arises from perivascular myoid cells (pericytes), which are cells that normally surround small blood vessels. This tumor belongs to the family of perivascular tumors, which also includes myofibroma and glomus tumors. Myopericytomas most commonly present as a slow-growing, painless, well-circumscribed nodule in the subcutaneous tissue or dermis of the extremities, particularly the lower limbs. They can also occur in other locations including the head, neck, and trunk. The tumors are typically solitary, although rare cases of multifocal myope
How is Myopericytoma inherited?
Myopericytoma follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Myopericytoma typically begin?
Typical onset of Myopericytoma is adult. Age of onset can vary across affected individuals.
Which specialists treat Myopericytoma?
16 specialists and care centers treating Myopericytoma are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.